Skip to content
10-Q

Quarterly Report

INTERNATIONAL STEM CELL CORPORATION ISCO

0000950170-23-021741

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 8M sh
Current Liabilities Q1 2023 · Mar 31, 2023 $4.83M
Current Liabilities Q1 2023 · Dec 31, 2022 $4.64M
Total Liabilities Q1 2023 · Mar 31, 2023 $5.49M
Total Liabilities Q1 2023 · Dec 31, 2022 $5.36M
Current Assets Q1 2023 · Mar 31, 2023 $3.24M
Current Assets Q1 2023 · Dec 31, 2022 $2.96M
Total Assets Q1 2023 · Mar 31, 2023 $5.34M
Total Assets Q1 2023 · Dec 31, 2022 $5.14M
Eps Diluted Q1 2023 · Mar 31, 2023 $0.00
Eps Diluted Q1 2023 · Mar 31, 2022 $0.00
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Shares Diluted Q1 2023 · Mar 31, 2022 8M sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$23K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$4.51M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$4.59M
Sga Expense Q1 2023 · Mar 31, 2022 $832K
Rd Expense Q1 2023 · Mar 31, 2022 $137K
Net Income Q1 2023 · Mar 31, 2022 −$9K
Operating Income Q1 2023 · Mar 31, 2022 $25K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $725K
Revenue Q1 2023 · Mar 31, 2022 $2.02M